LIVE24 Aug 2026, 08:01 PM IST
Home / IPO / Goldline Pharmaceutical
LISTEDSME

Goldline Pharmaceutical IPO

Open 12th May 2026 · Close 14th May 2026 · Listing 19th May 2026

Verified 2026-08-2489% data coverage
Issue Price₹43.00
Listing Price₹59.75
Current Price
Listing Gain38.95%
Current Return

Financial Performance

Goldline Pharmaceutical IPO — dedicated financial performance page.

Financial Performance

31 Mar 2023

Assets19.39
Total Income19.85
EBITDA2.19
Profit After Tax0.26
NET Worth5.89
Reserves and Surplus2.08
Total Borrowing10.83

31 Mar 2024

Assets22.93
Total Income23.57
EBITDA4.30
Profit After Tax1.81
NET Worth7.86
Reserves and Surplus3.76
Total Borrowing11.13

31 Mar 2025

Assets26.28
Total Income28.06
EBITDA5.83
Profit After Tax2.83
NET Worth10.35
Reserves and Surplus1.65
Total Borrowing11.03

31 Dec 2025

Assets27.40
Total Income21.41
EBITDA4.16
Profit After Tax2.22
NET Worth12.36
Reserves and Surplus3.65
Total Borrowing9.47
Trend chart₹ crore